Copyright
©2014 Baishideng Publishing Group Inc.
World J Transplant. Sep 24, 2014; 4(3): 188-195
Published online Sep 24, 2014. doi: 10.5500/wjt.v4.i3.188
Published online Sep 24, 2014. doi: 10.5500/wjt.v4.i3.188
Table 1 Demographic features
r-ATG | Alemtuzumab | IL-2 receptor blocker | ||||
Steroid | No steroid | Steroid | No steroid | Steroid | No steroid | |
(n = 13001) | (n = 4862) | (n = 852) | (n = 2176) | (n = 15008) | (n = 1318) | |
Donor age (yr) | 39 ± 17 | 39 ± 17 | 41 ± 18 | 40 ± 17 | 37 ± 17 | 37 ± 17 |
Donor gender (M/F) (%) | 59/41 | 60/40 | 61/39 | 58/42 | 60/40 | 60/40 |
Donor death from CVA (%) | 43 | 40b | 41 | 43 | 40 | 36b |
ECD kidney (%) | 19 | 19 | 26 | 22b | 15 | 16 |
DCD kidney (%) | 9.8 | 8.9 | 14.1 | 10.9a | 5.3 | 6.7a |
Recipient age (yr) | 52 ± 13 | 53 ± 13d | 52 ± 13 | 53 ± 12 | 52 ± 13 | 54 ± 15d |
Recipient gender (M/F) (%) | 57/53 | 63/37d | 56/44 | 60/40a | 63/37 | 64/36 |
African American race (%) | 37 | 26d | 33 | 33 | 26 | 20d |
Diabetes (%) | 34 | 20d | 31 | 38b | 34 | 34 |
Pre-txp dialysis (%) | 91 | 88b | 88 | 88 | 91 | 87d |
Dialysis duration (mo) | 48 ± 35 | 43 ± 36d | 47 ± 37 | 50 ± 34 | 43 ± 33 | 41 ± 32 |
Peak PRA (%) | 18 ± 31 | 10 ± 22d | 19 ± 31 | 14 ± 27d | 9 ± 22 | 8 ± 20 |
HLA mismatches | 3.9 ± 1.8 | 3.8 ± 1.8a | 3.9 ± 1.8 | 3.7 ± 1.7b | 3.6 ± 1.9 | 3.5 ± 2.0 |
Cold ischemia (h) | 18.3 ± 8.2 | 18.5 ± 8.8 | 20.8 ± 8.7 | 20.5 ± 9.2 | 17.8 ± 7.9 | 17.4 ± 8.5 |
Delayed graft function (%) | 28.9 | 19.5d | 29.1 | 21.2d | 20.2 | 16.5 |
Discharged on tacrolimus (%) | 81 | 79b | 70 | 98d | 67 | 78d |
- Citation: Sureshkumar KK, Hussain SM, Thai NL, Ko TY, Nashar K, Marcus RJ. Impact of steroid maintenance on the outcomes in first-time deceased donor kidney transplant recipients: Analysis by induction type. World J Transplant 2014; 4(3): 188-195
- URL: https://www.wjgnet.com/2220-3230/full/v4/i3/188.htm
- DOI: https://dx.doi.org/10.5500/wjt.v4.i3.188